MLchartDataset catalogue

Anaxirone

Term · Oncology and biomedicine · MLC-T-ONC-010056

A synthetic triepoxide alkylating agent with potential antineoplastic activity. Anaxirone alkylates DNA via actual or derived epoxide groups, resulting in inhibition of DNA synthesis. This agent has been shown to exhibit a broad spectrum of antineoplastic activity against experimental tumors, including those resistant to other alkylating agents.

Table 1. Record
IdentifierMLC-T-ONC-010056
FieldOncology and biomedicine
AbbreviationTGU
Synonymstriglycidylurazol
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-010056",
  "term": "Anaxirone",
  "field": "Oncology and biomedicine",
  "definition": "A synthetic triepoxide alkylating agent with potential antineoplastic activity. Anaxirone alkylates DNA via actual or derived epoxide groups, resulting in inhibition of DNA synthesis. This agent has been shown to exhibit a broad spectrum of antineoplastic activity against experimental tumors, including those resistant to other alkylating agents.",
  "abbreviation": "TGU",
  "synonyms": [
    "triglycidylurazol"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/anaxirone/"
}

Record 1,055 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.